DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /PyrrolidinesPyrrolidines
  6. /Cemdisiran, terminal sugar modification-CAS 1436858-07-9
Chemical structure of CAS 1436858-07-9

Cemdisiran, terminal sugar modification-

CAS No.1436858-07-9
MDL No.N/A
MFC78H140N11O34P
MW1807.00
InChI KeyLQRNAUZEMLGYOX-LZVIIAQDSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1436858-07-9
Product NameCemdisiran, terminal sugar modification-
Heavy Atom Count124Rotatable Bond Count66
Atom Stereo Count17Bond Stereo Count0
HBA32HBD22
TPSA663.440 ŲCharge0
Exact Mass1805.93018Complexity2951.69
pKa4.180XLogP-5.707

Related Articles

Studies related to this compound and its mechanism of action

Inactivation of phosphoenolpyruvate carboxykinase by acetaldehyde.

Biochemical and biophysical research communications • Vol. 70, Issue 3 • 1976
PMID: 7256DOI: 10.1016/0006-291x(76)90686-0

Documentation

Similar Products

  • tri-GalNAc-COOH

    CAS No.1953146-81-0

  • Tris-GalNAc-b-PEG5-NHS ester

    CAS No.1953146-83-2

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact